Introduction
Mowat-Wilson syndrome (MWS) is a rare genetic disease that was first described by Mowat and Wilson in 1998 [1] . MWS is characterized by dysmorphic facial features; congenital anomalies such as Hirschsprung's disease, genitourinary anomalies, congenital heart defects, agenesis, or hypogenesis of the corpus callosum; eye defects; and intellectual disability. MWS is caused by mutations or deletions in the zinc finger E-box-binding homeobox-2 gene (ZEB2), and more than 180 different mutations have been identified thus far [2] . Approximately 200 MWS cases have been reported worldwide
Case
Our patient was a female born to non-consanguineous parents after 40 weeks of gestation with no perinatal problems. Her birth weight was 2.9 kg (−0.9 standard deviation score [SDS] ). There was no family history of congenital anomalies or intellectual disability. Hirschsprung's disease was diagnosed in the neonatal period. At 4 months of age, the patient underwent a Duhamel operation, and she was able to control her head movements; furthermore, at 8 months, she could roll over. However, at 18 months, she visited the outpatient clinic due to developmental delays. Her height and weight were 79 cm (−0.8 SDS) and 9 kg (−1.4 SDS), respectively. Her head circumference was 42 cm (−3.4 SDS). She could not sit unaided nor speak any meaningful words. Facial dysmorphism was noted, including hypertelorism, deep-set eyes, epicanthal folds, depressed nasal bridge, and large and posteriorly rotated ears. Cognitive adaptive test/clinical linguistic and auditory milestone scale developmental quotient scores at 14 months were 55.3% (age equivalent, 7.2 months) and 69.2% (age equivalent, 9 months), respectively. Echocardiography, abdominal ultrasonography, electroencephalography, brain magnetic resonance imaging, and automated brainstem response audiometry showed no abnormal findings. The patient showed myopia and delayed development visual function upon ophthalmologic evaluation.
Genomic DNA was isolated from the patient's peripheral leukocytes after informed consent was obtained from the parents. Ten exons and the corresponding exon-intron boundaries on ZEB2 were amplified by polymerase chain reaction. Direct sequencing was subsequently carried out using a BigDye v.3.1 terminator kit and ABI3130xl Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). A novel heterozygous frameshift variant, c.190dup(A) (p.S64Kfs*6) in exon 3, was subsequently identified (Fig. 1 ).
Discussion
In this report, we describe the second Korean patient who has been diagnosed with MWS and confirmed by molecular analysis. This patient presented with facial dysmorphism, developmental delays, and Hirschsprung's disease. MWS is characterized as a single-gene disorder caused by heterozygous mutation or deletion of ZEB2, which is located on chromosome 2q22. ZEB2 consists of 10 exons containing 1214 amino acids. The product of ZEB2 is the Smad-interacting transcription factor, which also plays various roles in development [4] . In our present case, a novel variant, c.190dup (p.S64Kfs*6), was identified in ZEB2. This duplication is located on the N-terminal region of ZEB2, resulting in premature termination at residue 70. This prematurely truncated protein has no zinc finger domain or homeodomain at its C terminus, both of which are essential for the proper function of ZEB2.
Patients with MWS are initially recognized by various clinical features, including intellectual disability, facial dysmorphism, Hirschsprung's disease, seizures, congenital heart defects, genitourinary anomalies, and eye defects. The frequencies of the clinical manifestations in previously reported cases as well as our present case are summarized in Table 1 [1, 5] . The characteristic facial features of MWS include a broad nasal bridge, rounded nasal tip, triangular jaw, broad medial eyebrows, and widely spaced and deep-set eyes, which are noted in most affected patients [1] .
Hirschsprung's disease is one of the major manifestations of MWS; this condition is also associated with high mortality in patients with MWS [6] . Therefore, it is important to diagnose Hirschsprung's disease in patients with MWS, especially in those with gastrointestinal symptoms such as constipation and vomiting. In their first description of MWS, Mowat et al. [1] reported that 5 of 6 patients with MWS had Hirschsprung's disease. Bonnard et al. [6] reported that Hirschsprung's disease occurs in almost 50% of MWS patients. In another study, 70% of MWS patients developed Hirschsprung's disease as an isolated trait, with other congenital malformations noted in the remaining 30% of patients, such as congenital heart defects, gastrointestinal malformations, cleft palate, and craniofacial anomalies [7] .
It is important to note that Hirschsprung's disease is known to be associated with other syndromic disorders, for example, Shah-Waardenburg syndrome, which is a rare genetic disorder characterized by hypopigmentation of hair, sensorineural hearing loss. In addition, Hirschsprung's disease is occasionally associated with Bardet-Biedl syndrome, Kauffman-McKusick syndrome, Smith-Lemli-Opitz syndrome, and cartilagehair hypoplasia. Among these, Smith-Lemli-Opitz syndrome demonstrates similar clinical features as MWS, such as growth retardation, microcephaly, mental retardation, and hypospadias.
In addition, some patients with Bardet-Biedl syndrome present with eye defects such as pigmentary retinopathy, which can also develop in MWS patients [7] . Hence, careful physical examination for additional features of MWS and prompt genetic testing are needed to confirm any diagnosis.
In patients harboring normal ZEB2 sequences, karyotyping, fluorescent in situ hybridization analysis, multiplex ligationdependent probe amplification analysis, and chromosome microarray analysis can be performed, because some patients may carry chromosomal rearrangements at 2q22 that disrupt ZEB2 (~2%) or large genomic deletions at ZEB2 (15%) [3] . The first Korean MWS patient was diagnosed using high-resolution microarray analysis, which confirmed a 0.9-Mb deletion at 2q22.3 that implicated ZEB2 [3] .
Ophthalmological abnormalities have been described in approximately 4% of MWS patients [8, 9] , which range from mild features including ptosis, strabismus, and iris/retinal/optic disc colobomas, to more severe features such as optic nerve hypoplasia, retinal atrophy, and aplasia [10] . Epilepsy is one of the major manifestations of MWS. Approximately 70-75% patients develop seizures at a median age of 14.5 months that are often precipitated by fever [11] . The main seizure types include focal and atypical absence seizures [11] . At the onset of epilepsy, electroencephalography is normal or shows mild slowing of background activities. According to previous reports, epilepsy is refractory to treatment [11] . However, our patient did not develop epileptic episodes until 18 months and demonstrated normal findings on electroencephalography and brain magnetic resonance imaging. Nevertheless, careful monitoring of seizure development is warranted during follow-up evaluations.
Although MWS is characterized by distinct facial features, Hirschsprung's disease, and intellectual disability, this condition is rarely reported because it remains unknown among general practitioners. Our experiences reported herein should help to identify additional MWS cases. Appropriate genetic testing will also provide valuable information for confirming diagnoses, as well as providing genetic counseling to family members.
